Oncolytics Biotech Inc. (NASDAQ:ONCY) is set to announce second quarter earning results on Tuesday 4th August 2020, after market close.
Previous Quarter Performance
Oncolytics Biotech Inc. unwinded loss for the first quarter of $ 0.03 per share, from the revenue of . The quarterly earnings enlarged 10.00 percent while revenues compared with the same quarter last year.
According to street consensus, revenue of was expected for the first quarter The bottom line results street analysts by $ 0.08 or , at the same time, top line results analysts by $ 1.83 million or .
Stock Performance
According to the previous trading day, closing price of ONCY was $ 2.04, representing a 482.86 % increase from the 52 week low of $ 0.35 and a 66.11 % decrease over the 52 week high of $ 6.02.
The company has a market capital of $ 81.39 million and is part of the Healthcare sector and Biotechnology industry.
Conference Call
Oncolytics Biotech Inc. will be hosting a conference call at 4:30 PM eastern time on 4th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.oncolyticsbiotech.com
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. The company has co-development agreement with Merck KGaA and Pfizer Inc.
